Advances in advanced prostate cancer - the continuing journey

BJU Int. 2016 Jul;118(1):17-9. doi: 10.1111/bju.13350. Epub 2015 Nov 4.

Authors

Heather Payne¹, Reena Davda¹, Robert Jones², Simon Crabb³, Janis Troup⁴, Simon Hughes⁵

Affiliations

¹ Department of Oncology, University College Hospital London, London, UK.
² Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.
³ Department of Medical Oncology, University Hospital Southampton, Southampton, UK.
⁴ British Uro-Oncology Group, London, UK.
⁵ Department of Oncology, Guy's Hospital, London, UK.

PMID: 26456636
DOI: 10.1111/bju.13350

No abstract available

MeSH terms

Androgen Antagonists / therapeutic use*
Antineoplastic Agents / therapeutic use*
Clinical Trials as Topic
Disease Progression
Docetaxel
Drug Therapy, Combination* / trends
Evidence-Based Medicine
Humans
Male
Practice Patterns, Physicians'
Prostatic Neoplasms / drug therapy*
Taxoids / therapeutic use*

Substances

Androgen Antagonists
Antineoplastic Agents
Taxoids
Docetaxel